Reports about problems associated with power morcellation in gynecologic surgery led to safety warnings in November 2014 by the Food and Drug Administration (FDA) and the Joint Commission.
Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite.
This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:
Not a subscriber? That’s OK, subscribe today! OR Manager offers all-access subscriptions at an affordable rate.
With your subscription – or your team’s group subscription – you’ll receive access to all that OR Manager has to offer,
including our monthly issues, CE credit opportunities, job postings, and discounts to our industry-leading conferences.
Explore Subscription Options
Please contact our Customer Service Team if you are unable to log in at firstname.lastname@example.org
ORs rebounding from the financial impact of COVID-19 are looking…
Find out more
Orientation is the backbone of a sustainable workforce. Part 2…
GENERAL Disclaimer: The views expressed in this article are those…